SEC Form 4 · accession 0000914190-16-000740

Arno Therapeutics, Inc · ARNI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 15, 2016

Accepted (ET)

Aug 17, 2016 · 6:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001195116

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Aug 15, 2016	P$0	349,168	—	A	1,696,495	I	By Pontifax (Cayman) II L.P.
Common Stock^F3,F2	Aug 15, 2016	P$0	263,017	—	A	1,277,905	I	By Pontifax (Israel) II L.P.
Common Stock^F4,F2	Aug 15, 2016	P$0	102,100	—	A	496,068	I	By Pontifax (Israel) II - Individual Investors L.P.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
2016 Series F Warrants (right to buy)^F1,F2	$0.4375	Aug 15, 2016	P	174,584	A	Aug 16, 2016	Aug 16, 2021	Common Stock	174,584	174,584	I
2016 Series F Warrants (right to buy)^F3,F2	$0.4375	Aug 15, 2016	P	131,508	A	Aug 15, 2016	Aug 15, 2021	Common Stock	131,508	131,508	I
2016 Series F Warrants (right to buy)^F4,F2	$0.4375	Aug 15, 2016	P	51,050	A	Aug 15, 2016	Aug 16, 2021	Common Stock	51,050	51,050	I

F1The reported securities are included within 349,168 Issuer units committed to purchase by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
F2The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3The reported securities are included within 263,017 Issuer units committed to purchase by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
F4The reported securities are included within 102,100 Issuer units committed to purchase by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.